drugset / Trial / NCT06070597
A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety
RandomizedCrossoverDouble-blindTreatment
Summary
This study aims to evaluate the effects of iclepertin in the range of therapeutic to supra-therapeutic exposures on the (QT/QTc): Electrocardiogram (ECG) time interval from the start of the QRS complex (ECG time interval) to the end of the T wave / QT interval corrected for heart rate, e.g. using the method of Fridericia or Bazett interval and other ECG parameters.
Timeline
- Start
- 2024-01-25
- Primary completion
- 2024-06-05
- Completion
- 2024-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iclepertin | Small molecule | — | Oral |
| Subject | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.